National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis

References

• Steinbach WJ. Invasive aspergillosis in pediatric patients. Curr Med Res Opin. 2010;26(7):1779–1787.
   PubMed Web of Science ®Google Scholar
• Auberger J, Lass-Flörl C, Ulmer H, et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol. 2008;88(5):508–515.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Lemström K, Suojaranta-Ylinen R, et al. Control of early Aspergillus mortality after lung transplantation: outcome and risk factors. Transplant Proc. 2010;42(10):4459–4464.
   PubMed Web of Science ®Google Scholar
• Baddley JW, Stephens JM, Ji X, et al. Aspergillosis in Intensive Care Unit (ICU) patients: epidemiological and economic outcomes. BMC Infect Dis. 2013;13:29.
   PubMed Web of Science ®Google Scholar
• Taccone FS, Van Den Abeele AM, Bulpa P, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes. Crit Care. 2015;19(1):7.
   PubMedGoogle Scholar
• Alshabani K, Haq A, Miyakawa R, et al. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Rev Respir Med. 2015;9(1):89–96.
   PubMed Web of Science ®Google Scholar
• Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173(7):707–717.
   PubMed Web of Science ®Google Scholar
• Pasqualotto AC, Denning DW. Post-operative aspergillosis. Clin Microbiol Infect. 2006;12(11):1060–1076.
   PubMed Web of Science ®Google Scholar
• Baddley JW. Clinical risk factors for invasive aspergillosis. Med Mycol. 2011;49(Suppl 1):S7–S12.
   PubMed Web of Science ®Google Scholar
• Chakrabarti A1, Chatterjee SS, Das A, et al. Invasive aspergillosis in developing countries. Med Mycol. 2011;49(Suppl 1):S35–47.
   PubMedGoogle Scholar
• Waness A, El-Sameed YA, Mahboub B, et al. Respiratory disorders in the Middle East: a review. Respirology. 2011;16(5):755–766.
   PubMed Web of Science ®Google Scholar
• Steinbach WJ, Marr KA, Anaissie EJ, et al. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry. J Infect. 2012;65(5):453–464.
   PubMed Web of Science ®Google Scholar
• Salman N, Törün SH, Budan B, et al. Invasive aspergillosis in hematopoietic stem cell and solid organ transplantation. Expert Rev Anti Infect Ther. 2011;9(3):307–315.
   PubMed Web of Science ®Google Scholar
• Lamoth F, Calandra T. Early diagnosis of invasive mould infections and disease. J Antimicrob Chemother. 2017;72(suppl_1):i19–i28.
   PubMedGoogle Scholar
• Musher B, Fredricks D, Leisenring W, et al. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol. 2004;42(12):5517–5522.
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. PRISMA-P Group.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P). Syst Rev. 2015;4:1.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. European organization for research and treatment of cancer/invasive fungal infections cooperative group; national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. revised definitions of invasive fungal disease from the european organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• Blot SI, Taccone FS, Van Den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186(1):56–64.
   PubMed Web of Science ®Google Scholar
• Badiee P, Hashemizadeh Z, Ramzi M, et al. Non-invasive methods to diagnose fungal infections in pediatric patients with hematologic disorders. Jundishapur J Microbiol. 2016;9(11):e41573.
   PubMed Web of Science ®Google Scholar
• Zarrinfar H, Mirhendi H, Fata A, et al. Detection of Aspergillus flavus and A. fumigatus in bronchoalveolar lavage specimens of hematopoietic stem cell transplants and hematological malignancies patients by real-time polymerase chain reaction, Nested PCR and mycological assays. Jundishapur J Microbiol. 2015;8(1):e13744.
   PubMed Web of Science ®Google Scholar
• Zarrinfar H, Makimura K, Satoh K, et al. Incidence of pulmonary aspergillosis and correlation of conventional diagnostic methods with nested PCR and real-time PCR assay using BAL fluid in intensive care unit patient. J Clin Lab Anal. 2013;27(3):181–185.
   PubMed Web of Science ®Google Scholar
• Hedayati MT, Khodavaisy S, Alialy M, et al. Invasive aspergillosis in intensive care unit patients in Iran. Acta Medica (Hradec Kralove). 2013;56(2):52–56.
   PubMedGoogle Scholar
• Nabili M, Shokohi T, Janbabaie G, et al. Detection of invasive aspergillosis in bone marrow transplant recipients using real-time PCR. J Glob Infect Dis. 2013;5(2):68–75.
   PubMedGoogle Scholar
• Zarrinfar H, Saber S, Kordbacheh P, et al. Mycological microscopic and culture examination of 400 Bronchoalveolar Lavage (BAL) Samples. Iran J Public Health. 2012;41(7):70–76.
   PubMed Web of Science ®Google Scholar
• Khorvash F, Meidani M, Babaei L, et al. Galactomannan antigen assay from bronchoalveolar lavage fluid in diagnosis of invasive pulmonary aspergillosis in intensive care units patients. Adv Biomed Res. 2014;3:68.
   PubMedGoogle Scholar
• Badiee P, Karimi M, Alborzi A, et al. Invasive aspergillosis in pediatric hematology oncology ward. Iran J Blood Cancer. 2010;2(2):67–70.
   Google Scholar
• Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377–384.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. (2012). Available from: http://wwwohrica/programs/clinical_epidemiology/oxfordasp
   Google Scholar
• Higgins JP, Thompson SGQ. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–2223.
   PubMed Web of Science ®Google Scholar
• WHO G. WHO methods and data sources for global burden of disease estimates 2000-2011. Geneva: Department of Health Statistics and Information Systematics; 2013.
   Google Scholar
• Badiee P, Alborzi A, Malekhosseini SA, et al. Determining the incidence of aspergillosis after liver transplant. Exp Clin Transplant. 2010;8(3):220–223.
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A, et al. Invasive fungal infection in renal transplant recipients demonstrated by panfungal polymerase chain reaction. Exp Clin Transplant. 2007;5(1):624–629.
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A, et al. Fungal infections in solid organ recipients. Exp Clin Transplant. 2005;3(2):385–389.
   PubMedGoogle Scholar
• Badiee P, Alborzi A, Joukar M. Molecular assay to detect nosocomial fungal infections in intensive care units. Eur J Intern Med. 2011;22(6):611–615.
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A, et al. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transpl. 2007;13(7):1011–1016.
   PubMed Web of Science ®Google Scholar
• Badiee P, Alborzi A. Detection of Aspergillus species in bone marrow transplant patients. J Infect Dev Ctries. 2010;4(8):511–516.
   PubMed Web of Science ®Google Scholar
• Badiee P, Amirghofran AA, Ghazi Nour M, et al. Incidence and outcome of documented fungal endocarditis. Int J Cardiovasc Res. 2014;8(4):152–155.
   Google Scholar
• Badiee P, Alborzi A, Karimi M, et al. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J Infect Dev Ctries. 2012;6(4):352–357.
   PubMed Web of Science ®Google Scholar
• Badiee P, Kordbacheh P, Alborzi A, et al. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection. 2008;36(6):580–584.
   PubMed Web of Science ®Google Scholar
• Hedayati MT, Tagizadeh-Armaki M, Yazdani-Charati J, et al. Burden of fungal infections in Iran. J Infect Dev Ctries. 2018;12(10):910–918.
   Web of Science ®Google Scholar
• Maschmeyer G, Calandra T, Singh N, et al. Invasive mould infections: a multi-disciplinary update. Med Mycol. 2009;47(6):571–583.
   PubMed Web of Science ®Google Scholar
• Sanz Alonso MA, Jarque Ramos I, Salavert Lletí M, et al. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clin Microbiol Infect. 2006;12(suppl 7):2–6.
   Google Scholar
• Graf K, Khani SM, Ott E, et al. Five-years surveillance of invasive aspergillosis in a university hospital. BMC Infect Dis. 2011;8(11):163.
   Google Scholar
• Vallabhaneni S, Benedict K, Derado G, et al. Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000-2013. Open Forum Infect Dis. 2017;4(1):ofw268.
   PubMed Web of Science ®Google Scholar
• Garnaud C, Brenier-Pinchart MP, Thiebaut-Bertrand A, et al. Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital. J Infect. 2012;65(6):559–567.
   PubMed Web of Science ®Google Scholar
• Warnock DW. Trends in the epidemiology of invasive fungal infections. Nihon Ishinkin Gakkai Zasshi. 2007;48(1):1–12.
   PubMedGoogle Scholar
• Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43(5):577–584.
   PubMed Web of Science ®Google Scholar
• Kiertiburanakul S, Thibbadee C, Santanirand P. Invasive aspergillosis in a tertiary-care hospital in Thailand. J Med Assoc Thai. 2007;90(5):895–902.
   PubMedGoogle Scholar
• Zarrinfar H, Mirhendi H, Makimura K, et al. Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients. Mycopathologia. 2013;176(5–6):377–385.
   PubMed Web of Science ®Google Scholar
• Tabarsi P, Soraghi A, Marjani M, et al. Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients. Exp Clin Transplant. 2012;10(3):278–281.
   PubMed Web of Science ®Google Scholar
• Marjani M, Tabarsi P, Najafizadeh K, et al. Pulmonary aspergillosis in solid organ transplant patients: a report from Iran. Transplant Proc. 2008;40(10):3663–3667.
   PubMed Web of Science ®Google Scholar
• Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44–69.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32(3):358–366.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis. 2000;30(4):696–709.
   PubMed Web of Science ®Google Scholar
• Scully EP, Baden LR, Katz JT. Fungal brain infections. Curr Opin Neurol. 2008;21(3):347–352.
   PubMed Web of Science ®Google Scholar
• Bassiri JS, Khaksar AA. Deep-seated fungal infections in immunocompromised patients in iran. Iran J Allergy Asthma Immunol. 2008;4(1):27–32.
   Google Scholar
• Brissaud O, Guichoux J, Harambat J, et al. Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensive Care. 2012;2(1):6.
   PubMedGoogle Scholar
• Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100(13):4358–4366.
   PubMed Web of Science ®Google Scholar
• Selby R, Ramirez CB, Singh R, et al. Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg. 1997;132(3):304–310.
   PubMedGoogle Scholar
• Singh N, Arnow PM, Bonham A, et al. Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation. 1997;64(5):716–720.
   PubMed Web of Science ®Google Scholar
• Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005;241(6):905–916.
   PubMed Web of Science ®Google Scholar
• Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis. 2003;36(1):46–52.
   PubMed Web of Science ®Google Scholar
• Limaye AP, Corey L, Koelle DM, et al. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet. 2000;356(9230):645–649.
   PubMed Web of Science ®Google Scholar
• Rubin RH, Kemmerly SA, Conti D, et al. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis. Transpl Infect Dis. 2000;2(3):112–117.
   PubMedGoogle Scholar
• Bhat V, Joshi A, Sarode R, et al. Cytomegalovirus infection in the bone marrow transplant patient. World J Transplant. 2015;5(4):287–291.
   PubMedGoogle Scholar
• Razonable RR, Humar A. AST Infectious Diseases Community of Practice, Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):93–106.
   PubMedGoogle Scholar
• Issa NC, Fishman JA. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis. 2009;48(6):772–786.
   PubMed Web of Science ®Google Scholar
• Nikeghbalian S, Malek-Hosseini SA, Salahi H, et al. Pancreas transplantation in Shiraz organ transplant center; the first Iranian experience. Arch Iran Med. 2008;11(5):490–496.
   PubMedGoogle Scholar
• Brumage LK, Wright TL. Treatment for recurrent viral hepatitis after liver transplantation. J Hepatol. 1997;26(2):440–445.
   PubMed Web of Science ®Google Scholar
• Cheng CH, Lee CF, Soong RS, et al. Risk factors and clinical outcomes of ventilator-associated pneumonia in patients on the liver transplant waiting list. Transplant Proc. 2012;44(3):762–764.
   PubMed Web of Science ®Google Scholar
• Singh N, Pruett TL, Houston S, et al. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl. 2006;12(8):1205–1209.
   PubMed Web of Science ®Google Scholar
• Segal BH, Romani LR. Invasive aspergillosis in chronic granulomatous disease. Med Mycol. 2009;47(Suppl 1):S282–90.
   PubMed Web of Science ®Google Scholar
• Song E, Jaishankar GB, Saleh H, et al. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy. 2011;9(1):10.
   PubMedGoogle Scholar
• Movahedi M, Aghamohammadi A, Rezaei N, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004;134(3):253–259.
   PubMed Web of Science ®Google Scholar
• Khalilzadeh S, Bloorsaz MR, Mansouri D, et al. Clinical and radiological aspects of chronic granulomatous disease in children: a case series from Iran. Iran J Allergy Asthma Immunol. 2006;5(2):85–88.
   PubMedGoogle Scholar
• Losada L, Sugui JA, Eckhaus MA, et al. Genetic analysis using an isogenic mating pair of Aspergillus fumigatus identifies azole resistance genes and lack of MAT locus’s role in virulence. PLoS Pathog. 2015;11(4):e1004834.
   PubMed Web of Science ®Google Scholar
• Hohl TM, Feldmesser M. Aspergillus fumigatus: principles of pathogenesis and host defense. Eukaryote Cell. 2007;6(11):1953–1963.
   PubMedGoogle Scholar
• Pasqualotto AC. Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus. Med Mycol. 2009;47(Suppl 1):S261–70.
   PubMedGoogle Scholar
• Chauhan YS, Wright G, Rachaputi NC. Modelling climatic risks of aflatoxin contamination in maize. Aust J Exp Agric. 2008;48:358–366.
   Google Scholar
• Medina A, Rodriguez A, Magan N. Effect of climate change on Aspergillus flavus and aflatoxin B1 production. Front Microbiol. 2014;5:348.
   PubMed Web of Science ®Google Scholar
• Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011;20(121):156–174.
   PubMedGoogle Scholar
• Aliff TB, Maslak PG, Jurcic JG, et al. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin. Cancer. 2003;97(4):1025–1032.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis DP, Hachem R, Lewis RE, et al. Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies. Cancer. 2003;98(2):292–299.
   PubMed Web of Science ®Google Scholar
• Falcone M, Massetti AP, Russo A, et al. Invasive aspergillosis in patients with liver disease. Med Mycol. 2011;49(4):406–413.
   PubMed Web of Science ®Google Scholar
• Marr KA, Boeckh M, Carter RA, et al. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. 2004;39(6):797–802.
   PubMed Web of Science ®Google Scholar
• Singh N, Limaye AP, Forrest G, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006;81(3):320–326.
   PubMed Web of Science ®Google Scholar
• Verweij PE. Advances in diagnostic testing. Med Mycol. 2005;43(Suppl 1):S121–4.
   PubMedGoogle Scholar
• Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33(11):1824–1833.
   PubMed Web of Science ®Google Scholar
• Chamilos G, Kontoyiannis DP. Defining the diagnosis of invasive aspergillosis. Med Mycol. 2006;44(Supplement_1):S163–S173.
   PubMedGoogle Scholar
• Desai R, Ross LA, Hoffman JA. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr Infect Dis J. 2009;28(4):283–286.
   PubMed Web of Science ®Google Scholar
• Hsu LY, Ding Y, Phua J, et al. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infect Dis. 2010;10:44.
   PubMed Web of Science ®Google Scholar
• Maertens J, Maertens V, Theunissen K, et al. Lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis. 2009;49(11):1688–1693.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Leather H, Clancy CJ, et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biol Blood Marrow Transplant. 2011;17(7):1043–1050.
   PubMed Web of Science ®Google Scholar
• Taghizadeh-Armaki M, Hedayati MT, Moqarabzadeh V, et al. Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis. J Med Microbiol. 2017;66(7):898–904.
   PubMed Web of Science ®Google Scholar
• Marr KA, Laverdiere M, Gugel A, et al. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis. 2005;40(12):1762–1769.
   PubMed Web of Science ®Google Scholar
• Zou M, Tang L, Zhao S, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One. 2012;7(8):e43347.
   PubMed Web of Science ®Google Scholar
• Frías-de León MG, Acosta-Altamirano G, Duarte-Escalante E, et al. Molecular markers: an important tool in the diagnosis, treatment and epidemiology of invasive aspergillosis. Cir. 2014;82(1):109–118.
   Google Scholar